Locations:
May 3, 2022/Opinion

Working together for women’s brain health

Alzheimer brain disease, mental problems concept

In aLas Vegas Review-Journal op-ed, Jessica Caldwell, Ph.D., director of The Women’s Alzheimer’s Movement Prevention Center at Cleveland Clinic, called for innovative clinical care, science, education and funding to address Alzheimer’s disease in women.

Of the 6.5 million Americans currently diagnosed with Alzheimer’s disease, almost two-thirds are women.

In addition, more than half of those who care for people with Alzheimer’s are women.

Despite these differences, most doctors and researchers approach Alzheimer’s as though it were the same for men and women.

As a result, women’s brain health is undervalued, under-researched and not well-understood. To address this disparity, it will take innovative clinical care, science, education and funding. This work is the focus of The Women’s Alzheimer’s Movement Prevention Center at Cleveland Clinic — The WAM Prevention Center.

To read the entire article, visit the Las Vegas Review-Journal.

Latest from the Newsroom

Photo of scale wit a tape measure.

Cleveland Clinic Study Identifies Best Treatment Strategies for Weight Loss After Stopping GLP-1 Drugs

Cleveland Clinic's new teaching kitchen and food pantry at the Langston Hughes Community Health & Education Center

Cleveland Clinic Opens Teaching Kitchen and Food Pantry on Cleveland's East Side

VeloSano riders

$20.2 Million Raised for VeloSano, Funding Cancer Research at Cleveland Clinic in 2026

Photo of spine imaging.

Cleveland Clinic Expands Orthopaedic Care in the Mahoning Valley Through Acquisition of Youngstown Orthopaedic Associates Practice

Lobby of new Toronto location

Cleveland Clinic Canada Moves to New Downtown Toronto Location

Artist's rendering of gene therapy for high triglycerides.

Gene Editing Therapy Trial Dramatically Lowers Dangerous Blood Fat Levels

Artist's illustration of gene editing

Cleveland Clinic First-in-Human Trial Shows Gene-Silencing Therapy for High Cholesterol to Be Safe and Effective

Medical illustration of lipoprotein(a) molecule

Cleveland Clinic Trial Shows Novel Lipoprotein(a) Drug Did Not Reduce Major Cardiovascular Events After Nearly 5 Years